313 related articles for article (PubMed ID: 24363042)
1. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats.
Abdel-Raheem IT; Khedr NF
Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042
[TBL] [Abstract][Full Text] [Related]
2. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
3. Montelukast protects against renal ischemia/reperfusion injury in rats.
Sener G; Sehirli O; Velioğlu-Oğünç A; Cetinel S; Gedik N; Caner M; Sakarcan A; Yeğen BC
Pharmacol Res; 2006 Jul; 54(1):65-71. PubMed ID: 16584888
[TBL] [Abstract][Full Text] [Related]
4. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats.
Otunctemur A; Ozbek E; Cakir SS; Dursun M; Cekmen M; Polat EC; Ozcan L; Somay A; Ozbay N
Int Braz J Urol; 2015; 41(2):279-87. PubMed ID: 26005969
[TBL] [Abstract][Full Text] [Related]
6. The effects of montelukast against amikacin-induced acute renal damage.
Kose E; Beytur A; Dogan Z; Ekincioglu Z; Vardi N; Cinar K; Turkoz Y; Soysal H; Ekinci N
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):503-11. PubMed ID: 22696878
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of pentoxyfilline in renal toxicity after methotrexate administration.
Asvadi I; Hajipour B; Asvadi A; Asl NA; Roshangar L; Khodadadi A
Eur Rev Med Pharmacol Sci; 2011 Sep; 15(9):1003-9. PubMed ID: 22013722
[TBL] [Abstract][Full Text] [Related]
8. Leukotriene receptor blocker montelukast protects against burn-induced oxidative injury of the skin and remote organs.
Sener G; Kabasakal L; Cetinel S; Contuk G; Gedik N; Yeğen BC
Burns; 2005 Aug; 31(5):587-96. PubMed ID: 15935562
[TBL] [Abstract][Full Text] [Related]
9. Montelukast inhibits caspase-3 activity and ameliorates oxidative damage in the spinal cord and urinary bladder of rats with spinal cord injury.
Erşahin M; Çevik Ö; Akakın D; Şener A; Özbay L; Yegen BC; Şener G
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):131-9. PubMed ID: 22986158
[TBL] [Abstract][Full Text] [Related]
10. Antioxidant and anti-inflammatory effects of virgin coconut oil supplementation abrogate acute chemotherapy oxidative nephrotoxicity induced by anticancer drug methotrexate in rats.
Famurewa AC; Aja PM; Maduagwuna EK; Ekeleme-Egedigwe CA; Ufebe OG; Azubuike-Osu SO
Biomed Pharmacother; 2017 Dec; 96():905-911. PubMed ID: 29224791
[TBL] [Abstract][Full Text] [Related]
11. Protective effect of peroxisome proliferator activator receptor (PPAR)-α and -γ ligands against methotrexate-induced nephrotoxicity.
Ibrahim MA; El-Sheikh AA; Khalaf HM; Abdelrahman AM
Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):130-7. PubMed ID: 24521009
[TBL] [Abstract][Full Text] [Related]
12. Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production.
Helmy MM; El-Gowelli HM
Eur J Pharmacol; 2012 May; 683(1-3):294-300. PubMed ID: 22449377
[TBL] [Abstract][Full Text] [Related]
13. Renoprotective effect of celecoxib against gentamicin-induced nephrotoxicity through suppressing NFκB and caspase-3 signaling pathways in rats.
Abdelrahman RS; Abdelmageed ME
Chem Biol Interact; 2020 Jan; 315():108863. PubMed ID: 31628940
[TBL] [Abstract][Full Text] [Related]
14. Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.
Otunctemur A; Ozbek E; Cekmen M; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N
Ren Fail; 2013; 35(3):403-10. PubMed ID: 23342977
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of sepsis-induced pancreatic injury by leukotriene receptor antagonism via modulation of oxidative injury, and downregulation of inflammatory markers in experimental rats.
Hagar HH; Alhazmi SM; Arafah M; Bayoumy NM
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3425-3435. PubMed ID: 37962585
[TBL] [Abstract][Full Text] [Related]
16. Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats.
Beytur A; Köse E; Sarihan ME; Sapmaz HI; Dogan Z; Cetin A; Vardi N; Turkoz Y; Ekinci N
Ren Fail; 2012; 34(3):343-9. PubMed ID: 22260262
[TBL] [Abstract][Full Text] [Related]
17. Potential role of poly(ADP-ribose) polymerase (PARP) activation in methotrexate-induced nephrotoxicity and tubular apoptosis.
Dalaklioglu S; Sahin P; Ordueri EG; Celik-Ozenci C; Tasatargil A
Int J Toxicol; 2012; 31(5):430-40. PubMed ID: 22914891
[TBL] [Abstract][Full Text] [Related]
18. Neutrophil infiltration and oxidative stress may play a critical role in methotrexate-induced renal damage.
Kolli VK; Abraham P; Isaac B; Selvakumar D
Chemotherapy; 2009; 55(2):83-90. PubMed ID: 19145077
[TBL] [Abstract][Full Text] [Related]
19. Protective effect of alamandine on doxorubicin‑induced nephrotoxicity in rats.
Soltani Hekmat A; Chenari A; Alipanah H; Javanmardi K
BMC Pharmacol Toxicol; 2021 May; 22(1):31. PubMed ID: 34049594
[TBL] [Abstract][Full Text] [Related]
20. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
